Why Shares of Netflix, Peloton, and Zoom Plunged Today

What happened

Investors sold off stay-at-home stocks on Wednesday, following positive news on the COVID-19 vaccine front. By the close of trading, shares of Netflix (NASDAQ:NFLX), Peloton (NASDAQ:PTON), and Zoom Video Communications (NASDAQ:ZM) were down 5%, 8%, and 8%, respectively. 

So what

President Joe Biden said on Tuesday that the U.S. would have a sufficient supply of COVID-19 vaccines to inoculate every adult in the nation by the end of May. That’s two months earlier than his previous projection. 

Biden’s accelerated timeline follows the U.S. Food and Drug Administration’s decision to issue emergency use authorization to Johnson & Johnson for its single-shot coronavirus vaccine. J&J is working with its rival Merck to strengthen its manufacturing capabilities and accelerate the drug’s rollout. “Extraordinary times take extraordinary efforts,” J&J CEO Alex Gorsky said during an interview on CNBC yesterday. 

A person is pointing to a stock chart that rises sharply and then falls.

Investors rotated out of stay-at-home socks on Wednesday. Image source: Getty Images.

Many investors took the news as a reason to sell stocks that have performed well during the coronavirus pandemic. This included so-called stay-at-home leaders Netflix, Peloton, and Zoom.

Now what

The positive vaccine news will likely save countless lives and should certainly be celebrated. However, it doesn’t mean the end is nigh for businesses that have seen their sales grow during the COVID-19 crisis.

People will continue to watch movies on Netflix, exercise at home on their Peloton bikes, and use Zoom’s software to conduct video meetings. Yes, their growth could slow, but with their stocks pulling back sharply in recent weeks, this may already be reflected in their share prices. Thus, long-term investors may wish to use any further declines as an opportunity to buy shares of Zoom, Peloton, and Netflix at a discount from their recent highs.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.

You may also like...

Leave a Reply

Your email address will not be published. Required fields are marked *